We revealed that the expression of cardiac CCL24 and plasma CCL24 were higher in heart failure patients compared with normal donators, and blocking CCL24 in mice alleviated Ang II–induced electrical remodeling and heart failure. This evidence concerns the gene AGT and heart failure.